🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicentre, randomized controlled trial evaluates the effect and safe...
Status
Recruiting
Location
Guangdong Provincial Hospital of Chinese Medicine
Start Date
2026-01-15
Trial ID
NCT07337096
Treatments Being Tested
Immunotherapeutic approaches recently have demonstrated clinical efficacy i...
Status
Recruiting
Location
Aix-en-Provence - CH
Start Date
2022-05-02
Trial ID
NCT05255302
Treatments Being Tested
Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2022-12-14
Trial ID
NCT05493501
Patients with malignant pleural mesothelioma stage I-III who have undergone...
Status
Completed
Location
Vivantes Klinikum Neukölln, Klinik für Hämatologie, Onkologie und Palliativmedizin
Start Date
2019-02-04
Trial ID
NCT04177953
Treatments Being Tested
Pemetrexed has demonstrated a favorable response with minimal toxicity when...
Status
Completed
Location
Asan Medical Center
Start Date
2008-07
Trial ID
NCT01490437
Treatments Being Tested
This ALCHEMIST trial studies genetic testing in screening patients with sta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-09-26
Trial ID
NCT02194738
Treatments Being Tested
This is a study to assess the efficacy and safety of pembrolizumab (MK-3475...
Status
Completed
Location
Multiple Locations
Start Date
2014-08-25
Trial ID
NCT02142738
Treatments Being Tested
The purpose of this study is to determine whether erlotinib plus pemetrexed...
Status
Completed
Location
The first affiliated hospital of Guangzhou MC
Start Date
2012-01
Trial ID
NCT01578668
Treatments Being Tested
To explore the efficacy and safety of sintilimab, bevacizumab combined with...
Status
Recruiting
Location
Cancer Institute and Hospital,Chinese Academy of Medical Sciences
Start Date
2024-01-31
Trial ID
NCT06543069
Treatments Being Tested
Multicenter, open phase 2 study on patients with malignant mesothelioma. St...
Status
Completed
Location
UZ Antwerpen
Start Date
2009-10
Trial ID
NCT00996567
Treatments Being Tested